LONDON, April 5, 2017 /PRNewswire/ --
PharmaBoardroom today releases its new 34-page Healthcare & Life SciencesReview Special Report: Central & Eastern Europe 2017.
This special report offers companies, investors, policymakers, and stakeholders crucial insight into Central and Eastern Europe (CEE): a dynamic
The report features in-depth and exclusive facts and figures on the region's macroeconomy, healthcare systems, and pharmaceutical industries, as well as in-depth exclusive interviews with leading figures from public institutions and private companies, as well as comprehensive articles offering a snapshot of what the Czech Republic, Slovakia, Romania, and Hungary have to offer respectively to global investors.
"In the Czech Republic we have the right balance between sophisticated regulations in terms of transparency and quality, while being one of the fastest countries in the CEE region to grant market access" - Jakub Dvoracek, AIFP
"In the macroeconomic perspective, Slovakia today displays all the characteristics of a modern, successful, liberal market economy" - Vladimir Masar, Deloitte
"[Romania's] local producers offer competitive and more affordable prices compared to the rest of the EU and yet our quality standards are equivalent to and, in some cases, even superior due to the modernity of our factories." - Radu Cazacincu, Magistra C&C
"Hungary is no longer just a low-wage target country for investment, where assembly and manufacturing are carried out" - Peter Szijjarto, Minister of Foreign Affairs & Trade
Click here to register and download the report.
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All